Staging Results and Impact on Patient Management
Rated positive for MZL | BM/GI involvement | Ann Arbor classification | Changes due to CXCR4 PET/CT | |||||
---|---|---|---|---|---|---|---|---|
Patient no. | Conv. | CXCR4 | Conv. | CXCR4 | Conv. | CXCR4 | Staging | Treatment protocol |
1 | Yes* | No | I | — | Down | Deescalation to watch and wait (RTx) | ||
2 | Yes | Yes | BM | IV | IV | |||
3 | Yes | Yes | IV | IV | ||||
4 | Yes | Yes | GI | I | IV | Up | ||
5 | No | Yes | — | I | Up | Escalation to RTx (none) | ||
6 | No | No | — | — | ||||
7 | Yes | Yes | IV | IV | Escalation to CTx (RTx); at f/u: CXCR4+ lesion → RTx | |||
8 | Yes | Yes | I | IV | Up | Escalation to RTx of 3 lesions (RTx 1 lesion) | ||
9 | No | Yes | — | II | Up | Escalation to RTx (none) | ||
10 | Yes | Yes | III | III | ||||
11 | Yes | Yes | GI | GI, BM* | I | IV | Up | Escalation of RTx (smaller radiation field) |
12 | Yes | Yes | GI | GI | I | I | ||
13 | Yes | Yes | III | II | Down | |||
14 | Yes | Yes | IV | II | Down | |||
15 | Yes | Yes | BM* | BM* | IV | IV | ||
16 | Yes | Yes | BM | BM | IV | IV | ||
17 | Yes | Yes | BM | BM | IV | IV | ||
18 | Yes | Yes | I | I | ||||
19 | Yes | Yes | GI | GI | IV | IV | Deescalation to watch and wait (RTx) | |
20 | No | Yes | — | II | Up | escalation to RTx (none) | ||
21 | Yes | Yes | III | III | ||||
22 | No | Yes | GI* | — | II | Up |
↵* False-positive.
GI = gastrointestinal; Conv. = conventional staging; RTx = radiation; CTx = chemotherapy; f/u = follow-up.
Parentheses in last column indicate initially planned therapy.